nodularin and Neoplasms

nodularin has been researched along with Neoplasms* in 2 studies

Reviews

1 review(s) available for nodularin and Neoplasms

ArticleYear
Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development.
    Anti-cancer agents in medicinal chemistry, 2011, Volume: 11, Issue:1

    Microcystin-LR and nodularin, along with okadaic acid, are potent inhibitors of protein phosphatases 1 and 2A (PP1 and PP2A). The mechanisms of action of microcystin-LR and nodularin in the liver and that of okadaic acid, a potent tumor promoter on mouse skin, have attracted the attention of the scientists. This paper reviews several topics: new inhibitors of PP1 and PP2A with new chemical structures, structure-function relationships for both receptor binding and inhibition of protein phosphatases, the crystal structure of PP1 or PP2A-toxin complex, induction of gene expression and apoptosis. These subjects were studied by using in vitro and in vivo experimental systems. Two-stage carcinogenesis experiments with microcystin-LR and nodularin for the first time demonstrated that microcystin-LR is a new tumor promoter in rat liver initiated with diethylnitrosamine (DEN), and that nodularin is a potent tumor promoter associated with weak initiating activity in rat liver initiated with DEN. A working group of WHO (IARC) concluded that microcystin-LR is "possibly carcinogenic to humans" and that nodularin is "not classifiable as to carcinogenicity". Our studies revealed that chemical tumor promoters are inducers of TNF-α in the cells of target tissues and that TNF-α is an endogenous tumor promoter. This advance in carcinogenesis made it possible to look for the link between chemical tumor promoters and endogenous tumor promoters, such as TNF-α and IL-1. The carcinogenic features of TNF-α are described in this review, and the TNF-α inducing protein (Tipα) of Helicobacter pylori genome is presented as an example of a tumor promoter of human stomach cancer development.

    Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Humans; Marine Toxins; Microcystins; Neoplasms; Okadaic Acid; Peptides, Cyclic; Protein Tyrosine Phosphatases; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2011

Other Studies

1 other study(ies) available for nodularin and Neoplasms

ArticleYear
Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.
    PloS one, 2014, Volume: 9, Issue:3

    Microcystins are potent phosphatase inhibitors and cellular toxins. They require active transport by OATP1B1 and OATP1B3 transporters for uptake into human cells, and the high expression of these transporters in the liver accounts for their selective hepatic toxicity. Several human tumors have been shown to have high levels of expression of OATP1B3 but not OATP1B1, the main transporter in liver cells. We hypothesized that microcystin variants could be isolated that are transported preferentially by OATP1B3 relative to OATP1B1 to advance as anticancer agents with clinically tolerable hepatic toxicity. Microcystin variants have been isolated and tested for cytotoxicity in cancer cells stably transfected with OATP1B1 and OATP1B3 transporters. Microcystin variants with cytotoxic OATP1B1/OATP1B3 IC50 ratios that ranged between 0.2 and 32 were found, representing a 150-fold range in transporter selectivity. As microcystin structure has a significant impact on transporter selectivity, it is potentially possible to develop analogs with even more pronounced OATP1B3 selectivity and thus enable their development as anticancer drugs.

    Topics: Cell Line, Tumor; Humans; Inhibitory Concentration 50; Liver-Specific Organic Anion Transporter 1; Microcystins; Neoplasms; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Peptides, Cyclic; Solute Carrier Organic Anion Transporter Family Member 1B3

2014